Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cynata Therapeutics Ord Shs V.CYP


Primary Symbol: CYYNF

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.


OTCPK:CYYNF - Post by User

Bullboard Posts
Post by GarryJan1on Jul 30, 2019 8:05pm
90 Views
Post# 29977264

The sooner lithium gets on the Futures Exchange the better.

The sooner lithium gets on the Futures Exchange the better.Most analysts see a 3 to 4 times increase in battery grade lithium demand by 2025. The USA has to get the finger out. Trump might decide the military develop some projects for National Security also for the potential explosive properties of lithium.

LME progresses plan to provide pricing solutions for the lithium industry

10 June 2019

Over the past 18 months the London Metal Exchange (LME) has been working closely with the global lithium industry to meet the need for transparent and robust reference prices. Following extensive market engagement, the LME is announcing today that it is partnering with price reporting agency Fastmarkets to promote market uptake of a transparent and representative global lithium price. Continued adoption of reference pricing across the industry will pave the way for launch of a LME lithium futures contract.

Robin Martin, LME Head of Market Development said “In recent years there has been unprecedented price volatility in the lithium market, driven particularly by explosive electric vehicle (EV) battery demand. The LME has been approached by a number of industry players, including producers, end users and several leading automotive firms, to develop effective lithium price-risk management tools. We are delighted to be announcing the next step in that process today.”

In 2018 the LME requested proposals from several leading price reporting agencies with the objective of selecting the lithium market’s preferred price provider. The selection process included presentations delivered to the LME’s EV Metals Advisory Group, comprising key players from across the value chain, and was followed by extensive market discussion. The LME, on the basis of market views, selected Fastmarkets as its pricing partner due to their lithium prices being widely used across the industry combined with their leading pricing capabilities. Due to its chemical nature, lithium is not suitable for a physically-delivered contract, and hence the LME, together with its Advisory Group, believe that partnership with a price reporting agency represents the best route to a tradeable contract.

The LME is uniquely positioned to develop pricing solutions for the lithium market and will spend the coming months jointly promoting the industry’s transition towards reference pricing. In support of this, the Fastmarkets lithium prices will be made available free of charge through the LME’s website. The LME will continue to work with its Advisory Group and other industry participants to gauge appropriate timing for launch of a lithium contract.


Bullboard Posts